186 related articles for article (PubMed ID: 20374572)
1. Exfoliative cutaneous lupus erythematosus in German shorthaired pointer dogs: disease development, progression and evaluation of three immunomodulatory drugs (ciclosporin, hydroxychloroquine, and adalimumab) in a controlled environment.
Mauldin EA; Morris DO; Brown DC; Casal ML
Vet Dermatol; 2010 Aug; 21(4):373-82. PubMed ID: 20374572
[TBL] [Abstract][Full Text] [Related]
2. Treatment of exfoliative cutaneous lupus erythematosus in a German shorthaired pointer dog with mycophenolate mofetil.
Ferrigno A; Hoover K; Blubaugh A; Rissi D; Banovic F
Vet Dermatol; 2019 Aug; 30(4):350-e102. PubMed ID: 31038261
[TBL] [Abstract][Full Text] [Related]
3. German Shorthaired Pointer dogs with exfoliative cutaneous lupus erythematosus develop immune-complex membranous glomerulonephropathy.
Amerman HK; Cianciolo RE; Casal ML; Mauldin E
Vet Pathol; 2023 Nov; 60(6):843-848. PubMed ID: 37222157
[TBL] [Abstract][Full Text] [Related]
4. Familial cutaneous lupus erythematosus (CLE) in the German shorthaired pointer maps to CFA18, a canine orthologue to human CLE.
Wang P; Zangerl B; Werner P; Mauldin EA; Casal ML
Immunogenetics; 2011 Apr; 63(4):197-207. PubMed ID: 21132284
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effectiveness of calcineurin inhibitors in canine vesicular cutaneous lupus erythematosus.
Banovic F; Robson D; Linek M; Olivry T
Vet Dermatol; 2017 Oct; 28(5):493-e115. PubMed ID: 28439997
[TBL] [Abstract][Full Text] [Related]
6. A Missense Variant Affecting the C-Terminal Tail of UNC93B1 in Dogs with Exfoliative Cutaneous Lupus Erythematosus (ECLE).
Leeb T; Leuthard F; Jagannathan V; Kiener S; Letko A; Roosje P; Welle MM; Gailbreath KL; Cannon A; Linek M; Banovic F; Olivry T; White SD; Batcher K; Bannasch D; Minor KM; Mickelson JR; Hytönen MK; Lohi H; Mauldin EA; Casal ML
Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32028618
[TBL] [Abstract][Full Text] [Related]
7. Pathology in practice. Exfoliative cutaneous lupus erythematosus in a German Shorthaired Pointer.
Salas EN; Kotschwar JL
J Am Vet Med Assoc; 2014 Aug; 245(3):291-3. PubMed ID: 25029307
[No Abstract] [Full Text] [Related]
8. Successful treatment of a novel generalized variant of canine discoid lupus erythematosus with oral hydroxychloroquine.
Oberkirchner U; Linder KE; Olivry T
Vet Dermatol; 2012 Feb; 23(1):65-70, e15-6. PubMed ID: 21718370
[TBL] [Abstract][Full Text] [Related]
9. Clinical, histopathological and immunological characteristics of exfoliative cutaneous lupus erythematosus in 25 German short-haired pointers.
Bryden SL; White SD; Dunston SM; Burrows AK; Olivry T
Vet Dermatol; 2005 Aug; 16(4):239-52. PubMed ID: 16101795
[TBL] [Abstract][Full Text] [Related]
10. Interventions for cutaneous disease in systemic lupus erythematosus.
Hannon CW; McCourt C; Lima HC; Chen S; Bennett C
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD007478. PubMed ID: 33687069
[TBL] [Abstract][Full Text] [Related]
11. Ciclosporin therapy for canine generalized discoid lupus erythematosus refractory to doxycycline and niacinamide.
Banovic F; Olivry T; Linder KE
Vet Dermatol; 2014 Oct; 25(5):483-e79. PubMed ID: 24916384
[TBL] [Abstract][Full Text] [Related]
12. Mucocutaneous lupus erythematosus in dogs (21 cases).
Olivry T; Rossi MA; Banovic F; Linder KE
Vet Dermatol; 2015 Aug; 26(4):256-e55. PubMed ID: 26096899
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous lupus erythematosus in dogs: a comprehensive review.
Olivry T; Linder KE; Banovic F
BMC Vet Res; 2018 Apr; 14(1):132. PubMed ID: 29669547
[TBL] [Abstract][Full Text] [Related]
14. TNF alpha antagonist-induced lupus-like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists.
Williams VL; Cohen PR
Int J Dermatol; 2011 May; 50(5):619-25. PubMed ID: 21506984
[TBL] [Abstract][Full Text] [Related]
15. Experience with the use of hydroxychloroquine for the treatment of lupus erythematosus.
Momose Y; Arai S; Eto H; Kishimoto M; Okada M
J Dermatol; 2013 Feb; 40(2):94-7. PubMed ID: 23216212
[TBL] [Abstract][Full Text] [Related]
16. Effective treatment of canine chronic cutaneous lupus erythematosus variants with oclacitinib: Seven cases.
Harvey RG; Olivrī A; Lima T; Olivry T
Vet Dermatol; 2023 Feb; 34(1):53-58. PubMed ID: 36229964
[TBL] [Abstract][Full Text] [Related]
17. Pathology in practice. Psoriasiform lichenoid dermatitis.
Banovic F; Olivry T; Linder KE; Tobias JR
J Am Vet Med Assoc; 2014 Dec; 245(11):1237-9. PubMed ID: 26445736
[No Abstract] [Full Text] [Related]
18. Response to hydroxychloroquine in Japanese patients with lupus-related skin disease using the cutaneous lupus erythematosus disease area and severity index (CLASI).
Yokogawa N; Tanikawa A; Amagai M; Kato Y; Momose Y; Arai S; Eto H; Ikeda T; Furukawa F
Mod Rheumatol; 2013 Mar; 23(2):318-22. PubMed ID: 22581095
[TBL] [Abstract][Full Text] [Related]
19. Hydroxychloroquine administration for Japanese lupus erythematosus in Wakayama: a pilot study.
Ikeda T; Kanazawa N; Furukawa F
J Dermatol; 2012 Jun; 39(6):531-5. PubMed ID: 22168306
[TBL] [Abstract][Full Text] [Related]
20. Hydroxychloroquine modulates elevated expression of S100 proteins in systemic lupus erythematosus.
Wakiya R; Kameda T; Ueeda K; Nakashima S; Shimada H; Mansour MF; Kato M; Miyagi T; Miyatake N; Kadowaki N; Dobashi H
Lupus; 2019 Jun; 28(7):826-833. PubMed ID: 31068068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
